FilingSEC EDGAR6-K
NeuroSense Therapeutics Regains Minimum Bid Price Compliance but Faces Delisting Risk Over Market Value Requirement
· SEC accepted
StageOngoing listing compliance process
Filing content
The company regained compliance with the minimum bid price requirement but received a delisting notice for failing the minimum market value requirement and plans to request a hearing.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…